Hepatitis B big three yang transaminase elevation need antiviral treatment

Whether antiviral treatment is needed for hepatitis B big three yang aminotransferase elevation, it is necessary to comprehensively consider hepatitis B virus DNA level, liver inflammation degree, liver fibrosis degree and other factors, it is recommended to consult professional doctors, according to individual conditions to formulate treatment plan. Whether hepatitis B major transaminase elevation requires antiviral treatment requires a combination of factors, including hepatitis B virus DNA levels, liver inflammation, liver fibrosis, etc. The following is a specific analysis of this issue: 1. The definition and characteristics of hepatitis B big three yang refers to hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg) and hepatitis B core antibody in the five tests of hepatitis B.(Anti-HBc) positive condition. This usually indicates the presence of hepatitis B virus replication in the patient, but does not reflect the degree of liver inflammation and fibrosis.(such as alanine aminotransferase, aspartate aminotransferase) mainly exists in liver cells, when liver cells are damaged, aminotransferase will be released into the blood, resulting in elevated levels of aminotransferase in the blood. Elevated aminotransferase indicates that there may be inflammation or damage to the liver. 3. Indications for antiviral therapy In general, antiviral therapy may be beneficial for hepatitis B patients if they meet one of the following conditions: High HBV DNA level: HBV DNA quantitative test result is greater than or equal to 10^4 IU/ml (equivalent to 2000 copies/ml). Severe liver inflammation or fibrosis: significant liver inflammation as determined by liver biopsy or other examination (e.g. G2 or above) or fibrosis (e.g. S2 or above). There are high risk factors for cirrhosis or liver cancer: older age, male, long-term drinking, family history of cirrhosis, etc. 4. Comprehensive evaluation and individualized decision-making whether to carry out antiviral treatment need to consider the specific situation of the patient. The doctor will perform a detailed history collection, physical examination and related examinations (such as hepatitis B virus DNA quantification, liver function, liver B ultrasound, etc.) to assess the health status of the liver. In addition, personalized treatment plans will be developed taking into account factors such as patient age, gender, health status, and treatment willingness. 5. Other treatment options In addition to antiviral therapy, for patients with hepatitis B big three positive, there are other treatment measures, such as liver protection treatment, anti-fibrosis treatment, etc. These treatments can help alleviate liver inflammation, reduce fibrosis progression, but can not clear hepatitis B virus. 6. Regular monitoring and follow-up Regardless of whether antiviral treatment is given, hepatitis B patients need regular monitoring and follow-up. This includes regular liver function tests, hepatitis B virus DNA quantification, liver B ultrasound, etc. to detect changes in the disease in time and adjust the treatment plan as needed. To sum up, hepatitis B big three yang aminotransferase elevated need antiviral treatment needs comprehensive assessment of the specific situation of patients. It is recommended that patients consult a professional liver doctor, doctors will develop the most appropriate treatment plan according to the individual situation of patients. At the same time, patients should follow the doctor's advice, standardized treatment and follow-up to control the disease and prevent the progression of liver disease. It should be noted that for hepatitis B patients, especially hepatitis B patients, antiviral treatment needs long-term adherence, and some side effects may occur during the treatment process. Patients should closely cooperate with the doctor's treatment, take medicine on time, and pay attention to diet and lifestyle adjustments to improve the treatment effect and quality of life. In addition, family members and close contacts of hepatitis B patients should be vaccinated against hepatitis B vaccine in time to prevent infection.